CANOPY-A: A phase III, placebo-controlled study of canakinumab as adjuvant therapy in patients (pts) with surgically resected NSCLC

被引：0

作者：

Cho, B. C. ^{[1
]}

Chang, G-C. ^{[2
]}

Kim, Y-C. ^{[3
]}

Geater, S. ^{[4
]}

Saeteng, S. ^{[5
]}

Yang, C-T. ^{[6
]}

Goto, Y. ^{[7
]}

Lu, S. ^{[8
]}

Ardizzoni, A. ^{[9
]}

Barlesi, F. ^{[10
]}

De Marchi, P. ^{[11
]}

Paz-Ares, L. ^{[12
]}

Spigel, D. R. ^{[13
]}

Thomas, M. ^{[14
]}

Garon, E. B. ^{[15
]}

Leung, M. ^{[16
]}

Baum, J. ^{[17
]}

Zewen, Z. ^{[18
]}

Mookerjee, B. ^{[16
]}

Yang, J. C-H. ^{[19
]}

机构：

[1] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea

[2] Taichung Vet Gen Hosp, Dept Internal Med, Div Chest Med, Taichung, Taiwan

[3] ChonnamNatl Univ, Lung Canc Clin, Dept Internal Med, Hwasun Hosp, Jeollanam Do, South Korea

[4] Songklanagarind Hosp, Fac Med, Dept Internal Med, Songkhla, Thailand

[5] Chiang Mai Univ, Fac Med, Dept Surg, Chiang Mai, Thailand

[6] Chang Gung Mem Hosp, Dept Thorac Med, Taoyuan, Taiwan

[7] Natl Canc Ctr, Dept Thorac Oncol, Tokyo, Japan

[8] Shanghai Chest Hosp, Dept Med Oncol, Shanghai, Peoples R China

[9] St Orsola Malpighi Univ Polyclin, Dept Oncol & Hematol, Bologna, Italy

[10] Aix Marseille Univ, Dept Med Oncol, Marseille, France

[11] Hosp Canc Barretos, Dept Med Oncol, Sao Paulo, SP, Brazil

[12] Univ Hosp 12 Octubre, Dept Med Oncol, Madrid, Spain

[13] Sarah Cannon Res Inst, Dept Med Oncol, Nashville, TN USA

[14] Thoraxklin Univ Klinikum Heidelberg, Internist Onkol Thoraxtumoren, Dept Thorac Oncol Internal Med, German Ctr Lung Res DZL,TLRC H, Heidelberg, Germany

[15] UCLA TRIO US Network, David Geffen Sch Med, Dept Hematol Oncol, Los Angeles, CA USA

[16] Novartis Pharmaceut, Dept Oncol, E Hanover, NJ USA

[17] Novartis Inst BioMed Res, Dept Oncol, Cambridge, MA USA

[18] Novartis Pharmaceut, Dept Biostat, E Hanover, NJ USA

[19] Natl Taiwan Univ Hosp, Dept Med Oncol, Taipei, Taiwan

来源：

ANNALS OF ONCOLOGY | 2019年 / 30卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

531TiP

引用

页数：2

共 50 条

[1] CANOPY-A: a Phase 3 Study of Canakinumab as Adjuvant Therapy in Patients with Surgically Resected NSCLC
Spigel, D. R.
Garon, E. B.
Ardizzoni, A.
Barlesi, F.
Cho, B. C.
Marchi, P. D.
Goto, Y.
Lu, S.
Paz-Ares, L.
Thomas, M.
Mookerjee, B.
Leung, M.
Baum, J.
Zewen, Z.
Yang, J. C-H.
JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (11) : S1135 - S1136
[2] CANOPY-A: A Phase 3 Study of Canakinumab as Adjuvant Therapy in Patients with Surgically Resected NSCLC
Garon, E.
Ardizzoni, A.
Barlesi, F.
Cho, B. C.
De Marchi, P.
Goto, Y.
Lu, S.
Paz-Ares, L.
Spigel, D.
Thomas, M.
Mookerjee, B.
Arratia, P.
Baum, J.
Zewen, Z.
Yang, J.
JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S638 - S639
[3] CANOPY-A:A phase Ill study of canakinumab as adjuvant therapy in patients with surgically resected non -small cell lung cancer (NSCLC).
Garon, Edward B.
Ardizzoni, Andrea
Barlesi, Fabrice
Cho, Byoung Chul
De Marchi, Pedro
Goto, Yasushi
Lu, Shun
Paz-Ares, Luis G.
Spigel, David R.
Thomas, Michael
Mookerjee, Bijoyesh
Arratia, Pilar Cazorla
Baum, Jason
Lau, Yi-Yang Yvonne
Zhu, Zewen
Yang, James Chih-Hsin
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[4] CANOPY-A: Phase III study of canakinumab (CAN) as adjuvant therapy in patients (pts) with completely resected non-small cell lung cancer (NSCLC)
Garon, E. B.
Lu, S.
Goto, Y.
De Marchi, P. R.
Paz-Ares, L.
Spigel, D. R.
Thomas, M.
Yang, J. C-H.
Ardizzoni, A.
Barlesi, F.
Khanna, S.
Bossen, C.
Carbini, M.
Yovine, A.
Cho, B. C.
ANNALS OF ONCOLOGY, 2022, 33 (07) : S1414 - S1415
[5] CANOPY-A: A phase III, multicenter, randomized, double-blind, placebo-controlled trial evaluating canakinumab as adjuvant therapy in patients (pts) with completely resected non-small cell lung cancer (NSCLC).
Garon, Edward B.
Ardizzoni, Andrea
Barlesi, Fabrice
Cho, Byoung Chul
De Marchi, Pedro
Goto, Yasushi
Kowalski, Dariusz M.
Lu, Shun
Paz-Ares, Luis G.
Spigel, David R.
Spira, Alexander, I
Thomas, Michael
Leung, Mimi
Baum, Jason
Zhu, Zewen
Oliveira Portella, Maria do Socorro
Yang, James Chih-Hsin
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[6] Phase III Study of Canakinumab (ACZ885) as Adjuvant Therapy in Patients with Surgically Resected NSCLC
Garon, E.
Ardizzoni, A.
Barlesi, F.
Cho, B. C.
De Marchi, P.
Goto, Y.
Lu, S.
Paz-Ares, L.
Spigel, D.
Thomas, M.
Arratia, P. Cazorla
Baum, J.
Lau, Y.
Zheng, C.
Yang, J. C.
JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S1003 - S1004
[7] Canakinumab as Adjuvant Therapy in Patients with Completely Resected Non-Small Cell Lung Cancer (NSCLC): CANOPY-A Trial
Spira, A. I.
Ardizzoni, A.
Barlesi, F.
Cho, B. C.
De Marchi, P.
Goto, Y.
Kowalski, D.
Lu, S.
Paz-Ares, L.
Spigel, D. R.
Thomas, M.
Leung, M.
Baum, J.
Zhou, W.
Portella, S.
Yang, J. Chih-Hsin
Garon, E. B.
JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (01) : S25 - S25
[8] Canakinumab as Adjuvant Therapy in Patients With Completely Resected Non-Small Cell Lung Cancer: CANOPY-A Trial
Garon, Edward B.
Ardizzoni, Andrea
Barlesi, Fabrice
Cho, Byoung Chul
De Marchi, Pedro
Goto, Yasushi
Kowalski, Dariusz
Lu, Shun
Spigel, David R.
Thomas, Michael
Yang, James Chih-Hsin
Turri, Sabine
Zhou, Wen
Kreisl, Teri
Paz-Ares, Luis
MOLECULAR CANCER THERAPEUTICS, 2021, 20 (12)
[9] Canakinumab as Adjuvant Therapy in Patients with Completely Resected Non-Small Cell Lung Cancer: CANOPY-A Trial
Spira, A.
Ardizzoni, A.
Barlesi, F.
Cho, B.
de Marchi, P.
Goto, Y.
Kowalski, D.
Lu, S.
Paz-Ares, L.
Spigel, D.
Thomas, M.
Turri, S.
Rodrik-Outmezguine, V.
Zhou, W.
Kreisl, T.
Yang, J.
Garon, E.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
[10] Canakinumab as adjuvant therapy in patients with completely resected non-small cell lung cancer: CANOPY-A trial.
Spira, Alexander
Ardizzoni, Andrea
Barlesi, Fabrice
Cho, Byoung Chul
De Marchi, Pedro
Goto, Yasushi
Kowalski, Dariusz
Lu, Shun
Paz-Ares, Luis
Spigel, David R.
Thomas, Michael
Turri, Sabine
Rodrik-Outmezguine, Vanessa
Zhou, Wen
Kreisl, Terri
Yang, James Chih-Hsin
Garon, Edward B.
CANCER RESEARCH, 2021, 81 (13)

← 1 2 3 4 5 →